The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.

Stéphanie Le Guen, Prisca Honoré, Gwénaëlle Catheline, Marie-Claude Fournié-Zaluski, Bernard-Pierre Roques, Jean-Marie Besson
Brain Research. 1999-07-01; 834(1-2): 200-206
DOI: 10.1016/s0006-8993(99)01569-3

Lire sur PubMed

Auteurs Bordeaux Neurocampus